Manila Bulletin
Manila healthcare workers get Pfizer jab
Manila began administering Pfizer COVID-19 vaccines to medical front-liners on Thursday, May 13, at the Sta. Ana Hospital.
As of 12 p.m. on the first day, 170 front-liners had received their first doses.
The city government received 1,170 vials, equivalent to 7,020 doses, of the US-made Pfizer vaccine on Tuesday night.
Personnel from other district hospitals observed the initial rollout to prepare for future vaccinations.
Sta. Ana Hospital Director Dr. Grace Padilla highlighted that Pfizer vaccines have a 95 percent efficacy rate and require stringent handling at minus 70 degrees Celsius.
City Health Officer Dr. Arnold Pangan encouraged other medical front-liners to get vaccinated, stating that it is time to get vaccinated as more doses have arrived.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
The city of Manila began administering Pfizer-BioNTech COVID-19 vaccines to priority groups A1 (medical front-liners), A2 (senior citizens), and A3 (individuals with comorbidities) starting Tuesday, May 18, 2021.
Read more →
The Philippines received its first shipment of 193,050 Pfizer-BioNTech COVID-19 vaccine doses on Monday, May 10, via DHL Express flight LD457, supplied by the COVAX global facility.
+1
Read more →
San Juan City has commenced its COVID-19 vaccination program utilizing the Pfizer-BioNTech vaccine.
Read more →
The Philippines received over 2 million doses of the AstraZeneca COVID-19 vaccine on Saturday, May 8, marking the largest tranche from the COVAX Facility.
+2
Read more →
The Philippines is set to receive an additional 2.2 million Pfizer-BioNTech vaccine doses from the COVAX facility by the end of May, according to Vaccine Czar Carlito Galvez Jr.
Read more →